Imaging Diagnostic Systems, Inc.
IMDS
- -
USD
- -
- -
Imaging Diagnostic Systems, Inc.
IMDS
(- -)
Recent
price
- -
P/E
ratio
0
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Imaging Diagnostic Systems, Inc. engages primarily in the research, development, and marketing of non-invasive breast imaging systems, with its flagship product being the Computed Tomography Laser Mammography (CTLM) system. The CTLM system provides a unique laser imaging modality that enables 3-D visualization of dense breast tissue, offering an innovative approach to detecting breast abnormalities. The company’s core products include advanced breast imaging technology designed to improve diagnostic accuracy for breast cancer screening. Imaging Diagnostic Systems serves healthcare providers in the diagnostic imaging sector primarily within the United States but aims at expanding international distribution through exclusive distributor agreements. Founded in 1984 and headquartered in Florida, Imaging Diagnostic Systems operates as a medical device company specializing in women's imaging technologies. Recently, the company has signed multiple exclusive distributor agreements, expanding its global distribution network to include five additional countries, thereby broadening its international market reach. This strategic expansion aligns with its goal to increase adoption of its CTLM technology worldwide. Additionally, the company has been active in enhancing its product offerings with a focus on non-invasive, radiation-free imaging solutions for dense breast tissue, differentiating itself in the competitive diagnostic imaging industry. Imaging Diagnostic Systems has also undergone key leadership changes with the retirement of its CEO and the appointment of co-chairmen on the board, signaling an ongoing strategic transition to strengthen governance and market positioning. The company continues to emphasize innovation in breast imaging technology as it leverages partnerships and distribution agreements to enhance its commercial footprint. This approach positions Imaging Diagnostic Systems to capitalize on increasing demand for advanced breast cancer diagnostic tools, especially in regions with high incidence rates. Overall, Imaging Diagnostic Systems operates within the diagnostic imaging and medical devices industry, targeting healthcare institutions, radiology centers, and specialized breast imaging clinics. Its product portfolio centers around innovative, radiation-free breast imaging solutions, primarily the CTLM system, supported by a strategic push into global markets through distributor partnerships and operational restructuring to bolster leadership and sales capabilities. These initiatives reflect the company's commitment to expanding its technological leadership and market presence in the medical imaging field.